News

The Walk to Cure Juvenile Arthritis is Saturday, April 26, at the Mall of America.
The FDA has accepted Yuflyma as an interchangeable biosimilar to adalimumab for the treatment of multiple chronic ...
We acknowledge Aboriginal and Torres Strait Islander peoples as the First Australians and Traditional Custodians of the lands where we live, learn and work.
More than two million Australians have arthritis, a condition that causes joint pain and swelling. But many people don’t ...
Celltrion, Inc. announced that the U.S. Food and Drug Administration granted an interchangeable designation to ...
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing RulesCompany aims to accelerate access to much-needed biosimilar to reference ...
A mum from St Albans is taking part in the Manchester Marathon to raise awareness for her daughter's juvenile idiopathic arthritis diagnosis.